...
首页> 外文期刊>Bioscience, Biotechnology, and Biochemistry >New diagnostic method for Alzheimer's disease based on the toxic conformation theory of amyloid beta
【24h】

New diagnostic method for Alzheimer's disease based on the toxic conformation theory of amyloid beta

机译:基于淀粉样蛋白β的毒构象限形理论的阿尔茨海默病新诊断方法

获取原文
获取原文并翻译 | 示例
           

摘要

Recent investigations suggest that soluble oligomeric amyloid beta (A beta) species may be involved in early onset of Alzheimer's disease (AD). Using systematic proline replacement, solid-state NMR, and ESR, we identified a toxic turn at position 22 and 23 of A beta 42, the most potent neurotoxic A beta species. Through radicalization, the toxic turn can induce formation of the C-terminal hydrophobic core to obtain putative A beta 42 dimers and trimers. Synthesized dimer and trimer models showed that the C-terminal hydrophobic core plays a critical role in the formation of high molecular weight oligomers with neurotoxicity. Accordingly, an anti-toxic turn antibody (24B3) that selectively recognizes a toxic dimer model of E22P-A beta 42 was developed. Sandwich enzyme-linked immunosorbent assay with 24B3 and 82E1 detected a significantly higher ratio of A beta 42 with a toxic turn to total A beta 42 in cerebrospinal fluid of AD patients compared with controls, suggesting that 24B3 could be useful for early onset of AD diagnosis.
机译:最近的研究表明,可溶性低聚淀粉样蛋白β(Aβ)物种可参与阿尔茨海默病(AD)的早期发作。使用系统脯氨酸置换置换率,固态NMR和ESR,我们鉴定了β22的位置22和23的毒性转弯,这是最有效的神经毒性β物种。通过激动化,毒性转弯可以诱导C末端疏水核的形成,得到推定的β22二聚体和三聚体。合成二聚体和三聚体模型表明,C末端疏水芯在具有神经毒性的高分子量低聚物的形成中起着关键作用。因此,开发了选择性地识别E22P-Aβ22的毒性二聚体模型的抗毒转抗体(24b3)。夹心酶联免疫吸附测定与24b3和82e1检测到与对照组的AD患者的脑脊液中的β22的β22的β22的显着更高的比率,表明24b3可用于早期诊断的早期发病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号